PDGFRα (D842V) Assay Kit

Catalog #
79828
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PDGFRα (D842V) Assay Kit is designed to measure PDGFRα (D842V) activity for screening and profiling applications using ADP-Glo® Kinase Assay as a detection reagent.

Need us to run inhibitor screens or profile your compounds against PDGFRα (D842V)? Check out our Kinase Screening Services.

Synonyms
CD140A kit , PDGFR2 kit , MGC74795 kit , Rhe-PDGFRA kit, PDGFRα activity kit
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Supplied As
The PDGFRα (D842V) Assay Kit comes in a convenient 96-well format, with enough purified recombinant PDGFRα (D842V), Protein Tyrosine Kinase Substrate (Poly-Glu,Tyr 4:1), ATP, and kinase assay buffer for 96 enzyme reactions.
Materials Required But Not Supplied

ADP-Glo Kinase Assay (Promega #V6930)
Dithiothreitol (DTT, 1 M; optional)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator

Format
Catalog
Number

Component 

Amount 

Storage 
79633 PDGFRα (D842V), GST-Tag 2 µg -80°C

Avoid

freeze/
thaw cycles!
79334 5x Kinase assay buffer 1.5 ml -80°C
79686 ATP (500 μM) 100ml  -20°C
40217 Protein Tyrosine Kinase Substrate (Poly-Glu,Tyr 4:1) (10 mg/ml) 100 µl -20°C
79696 96-well plate, white 1 Room 
Temp
UniProt #
P16234
Background
Platelet-derived growth factor receptor A or PDGFRα has been implicated in regulation of cell growth and survival, apoptosis, and differentiation. It has been identified as a potential target in eosinophilic leukemia cancer, inflammatory breast cancer, and gastrointestinal stromal tumors. The D842V is one of the most predominant of the D842 mutations, which are related to gastrointestinal stromal tumors and are associated with resistance to tyrosine kinase inhibitors.
References

Evans, E., et al. A Precision Therapy Against Cancers Driven by KIT/PDGFRA Mutations; 2017, Science Translational Medicine Nov; 9(414): 1690.